Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Amy B. Wechsler currently holds 267,714 shares of Valeant Pharmaceuticals International, Inc. (VRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Amy B. Wechsler has been a net seller of VRX stock. They have purchased $0 and sold $350.9K worth of shares.
Amy B. Wechsler's most recent insider trade was on Mar 31, 2026, when they sold 1,273 shares at $5.40 per share.
Amy B. Wechsler serves as Executive at Valeant Pharmaceuticals International, Inc. (VRX). They have executed 48 insider transactions totaling $350.9K over their tenure at the company.
Amy B. Wechsler holds the position of Executive at Valeant Pharmaceuticals International, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 10 years and currently hold a stake valued at $0.
Amy B. Wechsler has shown a selling trading pattern, with $0 in total purchases and $350.9K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Amy B. Wechsler was on May 26, 2021, when they sold $350.9K worth of BHC shares. This transaction involved 11,037 shares at $31.79 per share.
Amy B. Wechsler currently owns 267,714 shares of Valeant Pharmaceuticals International, Inc. (VRX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Amy B. Wechsler's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Amy B. Wechsler has 48 Form 4 filings on record as an insider at Valeant Pharmaceuticals International, Inc..
Set alerts for Amy B. Wechsler and 40,000+ other insiders.